These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

639 related items for PubMed ID: 34045361

  • 1. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein.
    Hsu JC, Laurent-Rolle M, Pawlak JB, Wilen CB, Cresswell P.
    Proc Natl Acad Sci U S A; 2021 Jun 15; 118(24):. PubMed ID: 34045361
    [Abstract] [Full Text] [Related]

  • 2.
    Kirtsoglou E, Simpson B, Salisbury L, Baraitser L.
    ; 2020 Jun 15. PubMed ID: 36137063
    [Abstract] [Full Text] [Related]

  • 3. The segmented flavivirus Alongshan virus reduces mitochondrial mass by degrading STAT2 to suppress the innate immune response.
    Zhao Y, Sui L, Pan M, Jin F, Huang Y, Fang S, Wang M, Che L, Xu W, Liu N, Gao H, Hou Z, Du F, Wei Z, Bell-Sakyi L, Zhao J, Zhang K, Zhao Y, Liu Q.
    J Virol; 2024 Dec 10; ():e0130124. PubMed ID: 39655955
    [Abstract] [Full Text] [Related]

  • 4. Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo.
    Tsugawa Y, Furukawa K, Ise T, Takayama M, Ota T, Kuroda T, Shano S, Hashimoto T, Konishi H, Ishihara T, Sato M, Kamada H, Fukao K, Shishido T, Yoshikawa M, Takahashi T, Nagata S.
    PLoS One; 2024 Dec 10; 19(12):e0300297. PubMed ID: 39621673
    [Abstract] [Full Text] [Related]

  • 5. Evolution of enhanced innate immune evasion by SARS-CoV-2.
    Thorne LG, Bouhaddou M, Reuschl AK, Zuliani-Alvarez L, Polacco B, Pelin A, Batra J, Whelan MVX, Hosmillo M, Fossati A, Ragazzini R, Jungreis I, Ummadi M, Rojc A, Turner J, Bischof ML, Obernier K, Braberg H, Soucheray M, Richards A, Chen KH, Harjai B, Memon D, Hiatt J, Rosales R, McGovern BL, Jahun A, Fabius JM, White K, Goodfellow IG, Takeuchi Y, Bonfanti P, Shokat K, Jura N, Verba K, Noursadeghi M, Beltrao P, Kellis M, Swaney DL, García-Sastre A, Jolly C, Towers GJ, Krogan NJ.
    Nature; 2022 Feb 10; 602(7897):487-495. PubMed ID: 34942634
    [Abstract] [Full Text] [Related]

  • 6. Porcine deltacoronavirus nucleocapsid protein antagonizes JAK-STAT signaling pathway by targeting STAT1 through KPNA2 degradation.
    Hu Y, Hao C, Wang D, Guo M, Chu H, Jin X, Zu S, Ding X, Zhang H, Hu H.
    J Virol; 2024 Jul 23; 98(7):e0033424. PubMed ID: 38829137
    [Abstract] [Full Text] [Related]

  • 7. The cellular RNA helicase DDX1 interacts with coronavirus nonstructural protein 14 and enhances viral replication.
    Xu L, Khadijah S, Fang S, Wang L, Tay FP, Liu DX.
    J Virol; 2010 Sep 23; 84(17):8571-83. PubMed ID: 20573827
    [Abstract] [Full Text] [Related]

  • 8. Species-Specific Pathogenicity of Severe Fever with Thrombocytopenia Syndrome Virus Is Determined by Anti-STAT2 Activity of NSs.
    Yoshikawa R, Sakabe S, Urata S, Yasuda J.
    J Virol; 2019 May 15; 93(10):. PubMed ID: 30814285
    [Abstract] [Full Text] [Related]

  • 9. Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I.
    Stephenson ZA, Harvey RF, Pryde KR, Mistry S, Hardy RE, Serreli R, Chung I, Allen TE, Stoneley M, MacFarlane M, Fischer PM, Hirst J, Kellam B, Willis AE.
    Elife; 2020 May 20; 9():. PubMed ID: 32432547
    [Abstract] [Full Text] [Related]

  • 10. Evasion of the Innate Immune Type I Interferon System by Monkeypox Virus.
    Arndt WD, Cotsmire S, Trainor K, Harrington H, Hauns K, Kibler KV, Huynh TP, Jacobs BL.
    J Virol; 2015 Oct 20; 89(20):10489-99. PubMed ID: 26246580
    [Abstract] [Full Text] [Related]

  • 11. Australia in 2030: what is our path to health for all?
    Backholer K, Baum F, Finlay SM, Friel S, Giles-Corti B, Jones A, Patrick R, Shill J, Townsend B, Armstrong F, Baker P, Bowen K, Browne J, Büsst C, Butt A, Canuto K, Canuto K, Capon A, Corben K, Daube M, Goldfeld S, Grenfell R, Gunn L, Harris P, Horton K, Keane L, Lacy-Nichols J, Lo SN, Lovett RW, Lowe M, Martin JE, Neal N, Peeters A, Pettman T, Thoms A, Thow AMT, Timperio A, Williams C, Wright A, Zapata-Diomedi B, Demaio S.
    Med J Aust; 2021 May 20; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [Abstract] [Full Text] [Related]

  • 12. Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.
    Essink BJ, Shapiro C, Isidro MGD, Bradley P, Pragalos A, Bloch M, Santiaguel J, Frias MV, Miyakis S, Alves de Mesquita M, Berrè S, Servais C, Waugh N, Hoffmann C, Baba E, Schönborn-Kellenberger O, Wolz OO, Koch SD, Ganyani T, Boutet P, Mann P, Mueller SO, Ramanathan R, Gaudinski MR, Vanhoutte N.
    Hum Vaccin Immunother; 2024 Dec 31; 20(1):2408863. PubMed ID: 39422261
    [Abstract] [Full Text] [Related]

  • 13. Optimization of SARS-CoV-2 culture from clinical samples for clinical trial applications.
    Wooding D, Buist K, Romero-Ramirez A, Savage H, Watkins R, Bengey D, Greenland-Bews C, Thompson CR, Kontogianni N, Body R, Hayward G, Byrne RL, Gould S, CONDOR Steering Group, Myerscough C, Atkinson B, Shaw V, Greenhalf B, Adams E, Cubas-Atienzar A, Khoo S, Fletcher T, Edwards T.
    mSphere; 2024 Nov 21; 9(11):e0030424. PubMed ID: 39412283
    [Abstract] [Full Text] [Related]

  • 14. The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein.
    Mendoza-Ramírez NJ, García-Cordero J, Shrivastava G, Cedillo-Barrón L.
    J Immunol Res; 2024 Nov 21; 2024():9313267. PubMed ID: 38939745
    [Abstract] [Full Text] [Related]

  • 15. CMPK2 restricts Zika virus replication by inhibiting viral translation.
    Pawlak JB, Hsu JC, Xia H, Han P, Suh HW, Grove TL, Morrison J, Shi PY, Cresswell P, Laurent-Rolle M.
    PLoS Pathog; 2023 Apr 21; 19(4):e1011286. PubMed ID: 37075076
    [Abstract] [Full Text] [Related]

  • 16. CGRP inhibits SARS-CoV-2 infection of bronchial epithelial cells, and its pulmonary levels correlate with viral clearance in critical COVID-19 patients.
    Barbosa Bomfim CC, Génin H, Cottoignies-Callamarte A, Gallois-Montbrun S, Murigneux E, Sams A, Rosenberg AR, Belouzard S, Dubuisson J, Kosminder O, Pène F, Terrier B, Bomsel M, Ganor Y.
    J Virol; 2024 Sep 17; 98(9):e0012824. PubMed ID: 39162434
    [Abstract] [Full Text] [Related]

  • 17. Syk Facilitates Influenza A Virus Replication by Restraining Innate Immunity at the Late Stage of Viral Infection.
    Li Y, Liu S, Chen Y, Chen B, Xiao M, Yang B, Rai KR, Maarouf M, Guo G, Chen JL.
    J Virol; 2022 Apr 13; 96(7):e0020022. PubMed ID: 35293768
    [Abstract] [Full Text] [Related]

  • 18. Activation of alveolar epithelial ER stress by β-coronavirus infection disrupts surfactant homeostasis in mice: implications for COVID-19 respiratory failure.
    Murthy A, Rodriguez LR, Dimopoulos T, Bui S, Iyer S, Chavez K, Tomer Y, Abraham V, Cooper C, Renner DM, Katzen JB, Bentley ID, Ghadiali SN, Englert JA, Weiss SR, Beers MF.
    Am J Physiol Lung Cell Mol Physiol; 2024 Aug 01; 327(2):L232-L249. PubMed ID: 38860845
    [Abstract] [Full Text] [Related]

  • 19. Intertwined Dysregulation of Ribosomal Proteins and Immune Response Delineates SARS-CoV-2 Vaccination Breakthroughs.
    Maurya R, Shamim U, Mishra P, Swaminathan A, Raina A, Tarai B, Budhiraja S, Pandey R.
    Microbiol Spectr; 2023 Jun 15; 11(3):e0429222. PubMed ID: 37022180
    [Abstract] [Full Text] [Related]

  • 20. Antioxidants for female subfertility.
    Showell MG, Mackenzie-Proctor R, Jordan V, Hart RJ.
    Cochrane Database Syst Rev; 2020 Aug 27; 8(8):CD007807. PubMed ID: 32851663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.